Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-04-03
2007-04-03
Maier, Leigh C. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S090000, C514S110000
Reexamination Certificate
active
10724638
ABSTRACT:
The present invention provides aqueous Ifosfamide compositions and a process for their preparation, in which the compositions have a reduced toxicity over and above the concomitant use of the uroprotective agent, Mesna. Aqueous Ifosfamide compositions can be prepared at concentrations as high has 1,1000 mg/ml.
REFERENCES:
patent: 4727064 (1988-02-01), Pitha
patent: 4879286 (1989-11-01), Alam et al.
patent: 4952575 (1990-08-01), Sauerbier et al.
patent: 5158779 (1992-10-01), Gergely et al.
patent: 5227373 (1993-07-01), Alexander et al.
patent: 6407079 (2002-06-01), Müller et al.
patent: WO 99/18973 (1999-04-01), None
patent: WO 02/02125 (2002-01-01), None
patent: WO 03/051297 (2003-06-01), None
Cheung, B.W.Y., et al., “Brain delivery of carbamazepine during intravenous administration of polyethylene glycol and 2-hydroxypropyl-β-cyclodextrin formulations”, STP Pharma.
Daftary Gautam Vinod
Pai Srikanth Annappa
Rivankar Sangeeta Hanurmesh
Subbappa Praveen Kumar
Bharat Serums & Vaccines Ltd.
Kenyon & Kenyon LLP
Maier Leigh C.
LandOfFree
Aqueous ifosfamide compositions for parenteral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aqueous ifosfamide compositions for parenteral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aqueous ifosfamide compositions for parenteral... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3784997